Medical News

RSS

African-Americans without private health insurance less likely to receive kidney transplants

African-Americans and individuals without private health insurance are less likely than others to receive a kidney transplant before requiring dialysis, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN).

1 Feb 2013

Viewpoints: Congress must put entitlements on 'more sustainable path;' Reading, writing and mental health screenings

What's needed now is a clear, achievable plan to bring the debt and deficit under control for the long term. A crucial part of any such plan is promoting a more vigorous economy, possibly by simplifying the federal tax code. Another important piece is putting entitlements on a more sustainable path, reducing the drain on the Treasury. That means expanding on the 2010 healthcare law's efforts to increase efficiency, quality and innovation in healthcare.

1 Feb 2013

Mental health in young people: an interview with Professor Colum Dunne

Ireland, and many other countries, is witnessing increases in problematic and complex youth mental health challenges. In Ireland, specifically, there has been a rash of high profile cases where young people have unfortunately not been able to deal with stress, bullying and other issues.

1 Feb 2013

Condom use expectations less than 50% for all types of sexual encounters: Study

Researchers have found that African American women exhibit a higher risk for sexually transmitted infections including HIV/Aids. But what motivates this group of women to have sex? And when are they more likely to use protection?

31 Jan 2013

Selway signs definitive agreement to enter into business combination with HCCA

Selway Capital Acquisition Corporation announced today that it has signed a definitive agreement to enter into a business combination with Healthcare Corporation of America, Inc. (HCCA), which is one of the fastest growing PBM's in the market.

31 Jan 2013

ArQule, Daiichi Sankyo initiate enrollment in tivantinib Phase 3 trial for hepatocellular carcinoma

Daiichi Sankyo Company, Limited and ArQule, Inc. today announced that the first patient has been enrolled in the pivotal Phase 3 METIV-HCC (MET-high patients with tivantinib in HCC) trial of tivantinib (ARQ 197).

31 Jan 2013

Major East Coast academic medical center acquires BSD-500 Hyperthermia System

BSD Medical Corporation announced today that a major East Coast academic medical center has purchased a BSD-500 Hyperthermia System (BSD-500).

31 Jan 2013

SINEUP allows scientists to target individual genes in cells to increase protein production

One of the most innovative biotechnologies of the last decade has recently been developed. SINEUP allows scientists, for the first time, to target individual genes in cells to knockup, or increase, the amount of protein they make. The technique will improve Protein manufacture, analyse the function of genes and engineer improved cell function.

From Cell Guidance Systems 31 Jan 2013

Habitat for Humanity, Meridian Health Plan announce collaboration

Meridian Health Plan is teaming up with Habitat for Humanity to change lives through improving health and strengthening communities in Chicago's southern suburbs.

31 Jan 2013

Optofluidics to pre-launch Molecular NanoTweezer system in Feb. 2013

Optofluidics announces the pre-release of its Molecular NanoTweezer system - the most powerful optical trapping technology in the world - at SPIE Photonics West, BiOS and Biophysical Society annual meetings in Feb. 2013.

From Halo Labs 31 Jan 2013

Celsion's ThermoDox does not meet primary endpoint in Phase III HCC study

Celsion Corporation, a leading oncology drug development company, today announced that ThermoDox in combination with radiofrequency ablation (RFA) did not meet the primary endpoint of the Phase III HEAT Study in patients with hepatocellular carcinoma (HCC), also known as primary liver cancer.

31 Jan 2013

Span-America first quarter net income increases 21% to $1.4 million

Span-America Medical Systems, Inc. today reported higher sales and net income for the first quarter ended December 29, 2012.

31 Jan 2013

FDA approves Biotest's BIVIGAM to treat Primary Humoral Immunodeficiency

Biotest Pharmaceuticals Corporation (BPC), a wholly owned U.S. subsidiary of Biotest AG, recently announced the U.S. Food and Drug Administration's (FDA) approval of BIVIGAM, its new intravenous immune globulin, for the treatment of patients with Primary Humoral Immunodeficiency (PI).

31 Jan 2013

Kraton Polymers' Cariflex polyisoprene products to be showcased at MEDTEC Europe

Kraton Performance Polymers, Inc., a leading global producer of styrenic block copolymers and other engineered polymers, announces plans to showcase Cariflex polyisoprene products, the pure and clean alternative to natural rubber for high performance medical applications, at MEDTEC Europe in Stuttgart, Germany.

31 Jan 2013

Top-line results from Vanda's tasimelteon Phase IIb/III study on major depressive disorder

Vanda Pharmaceuticals Inc. today announced top-line results of the Phase IIb/III clinical study (MAGELLAN) in Major Depressive Disorder (MDD), investigating the efficacy and safety of tasimelteon as a monotherapy in the treatment of patients with MDD.

31 Jan 2013

Affymetrix fourth quarter total revenue increases 2% to $84.4 million

Affymetrix, Inc., today reported its operating results for the three and twelve months ended December 31, 2012.

31 Jan 2013

FDA allows Arteriocyte to commence Magellan System Phase I trial in thermal burn wounds

Arteriocyte, a leading biotechnology company with offices in Cleveland, Ohio and Hopkinton, Massachusetts announced today approval from the Food and Drug Administration (FDA) to initiate a Phase I clinical trial using its Magellan System technology in the treatment of thermal burn wounds.

31 Jan 2013

UnitedHealthcare launches UHC Research Institute

UHC is pleased to introduce the UHC Research Institute, an innovative program designed to provide the knowledge and insights its academic medical center (AMC) members need to lead the way in improving our nation's health care delivery system.

31 Jan 2013

DelMar announces second closing of $1.5M in private placement

DelMar Pharmaceuticals, Inc. today announced the second closing in a private placement consisting of approximately 1.9 million units of its securities to qualified accredited investors, for gross proceeds of approximately $1.5 million. The total amount raised in the private placement is $6.9 million.

31 Jan 2013

Velomedix commences rapid therapeutic hypothermia system pilot study in heart attack

Velomedix, a venture-backed medical device company advancing the field of therapeutic hypothermia, today announced the enrollment of the first patient in its VELOCITY pilot study.

31 Jan 2013

Medical News

African-Americans without private health insurance less likely to receive kidney transplants

Viewpoints: Congress must put entitlements on 'more sustainable path;' Reading, writing and mental health screenings

Mental health in young people: an interview with Professor Colum Dunne

Condom use expectations less than 50% for all types of sexual encounters: Study

Selway signs definitive agreement to enter into business combination with HCCA

ArQule, Daiichi Sankyo initiate enrollment in tivantinib Phase 3 trial for hepatocellular carcinoma

Major East Coast academic medical center acquires BSD-500 Hyperthermia System

SINEUP allows scientists to target individual genes in cells to increase protein production

Habitat for Humanity, Meridian Health Plan announce collaboration

Optofluidics to pre-launch Molecular NanoTweezer system in Feb. 2013

Celsion's ThermoDox does not meet primary endpoint in Phase III HCC study

Span-America first quarter net income increases 21% to $1.4 million

FDA approves Biotest's BIVIGAM to treat Primary Humoral Immunodeficiency

Kraton Polymers' Cariflex polyisoprene products to be showcased at MEDTEC Europe

Top-line results from Vanda's tasimelteon Phase IIb/III study on major depressive disorder

Affymetrix fourth quarter total revenue increases 2% to $84.4 million

FDA allows Arteriocyte to commence Magellan System Phase I trial in thermal burn wounds

UnitedHealthcare launches UHC Research Institute

DelMar announces second closing of $1.5M in private placement

Velomedix commences rapid therapeutic hypothermia system pilot study in heart attack

Voltammetry and machine learning for real-time neurotransmitter detection

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

Latest News